Human Abuse Liability study of Mallinckrodt's Oxycodone/paracetamol combination in recreational opioid abusers.

Trial Profile

Human Abuse Liability study of Mallinckrodt's Oxycodone/paracetamol combination in recreational opioid abusers.

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Oct 2014

At a glance

  • Drugs Oxycodone/paracetamol (Primary)
  • Indications Pain
  • Focus Pharmacodynamics
  • Most Recent Events

    • 12 Sep 2013 Results were presented at PAINWeek 2013, and in a Mallinckrodt media release.
    • 12 Sep 2013 New trial record
    • 04 Sep 2013 Primary endpoint 'Psychological-measures' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top